Indonesian Company, Afi Farma Officials Jailed Over Deadly Cough Syrup

Jakarta: An Indonesian court sentenced to jail on Wednesday the CEO and three other officials of a company whose cough syrup has been linked to the death of more than 200 children, for violating drug safety laws, the company’s lawyer said.

The Indonesian company, Afi Farma, was accused of producing cough syrups containing excess amounts of toxic material. Prosecutors charged the four officials for “consciously” not testing the ingredients, despite having the means and responsibility to do so, according to the charge sheet.

The company’s lawyer, Reza Wendra Prayogo, said they deny negligence and the company is considering whether to appeal.

The officials, including CEO Arief Prasetya Harahap, were sentenced to two years in prison by a court in the town of Kediri, in East Java province, where the company is based.

Prosecutors, who had sought up to nine years in prison for the accused, said that Afi Farma did not test the ingredients sent by its supplier and instead relied on certificates provided by them regarding product quality and safety.

Reza said in October that Indonesia’s drug regulator, BPOM, did not require drugmakers to do rigorous testing of ingredients.

The case comes as efforts grow worldwide to tighten oversight of drug supply chains after a wave of poisonings linked to contaminated cough syrups that killed dozens of children in countries such as Gambia and Uzbekistan.

Related Posts

  • Pharma
  • May 21, 2025
  • 120 views
Gland Pharma Q4 results: Profit dips 3% YoY to ₹187 crore; 1800% dividend announced

Gland Pharma Q4 Results: Pharma company Gland Pharma on Tuesday, May 20, posted a weak set of numbers for the fourth quarter of the financial year 2024-25 (Q4 FY25), recording…

  • Pharma
  • May 21, 2025
  • 236 views
Medical shop operating without licence raided, illegal stock seized

A medical shop in Alwal was raided by officials of the Telangana Drugs Control Administration (DCA) following a tip-off about illegal sale of medicines. During the inspection, officials discovered that…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Gland Pharma Q4 results: Profit dips 3% YoY to ₹187 crore; 1800% dividend announced

Gland Pharma Q4 results: Profit dips 3% YoY to ₹187 crore; 1800% dividend announced

Medical shop operating without licence raided, illegal stock seized

Medical shop operating without licence raided, illegal stock seized

Zydus Wellness posts 30% profit growth in FY25, Q4 net sales up 17% YoY

Zydus Wellness posts 30% profit growth in FY25, Q4 net sales up 17% YoY

Lupin to boost complex generics in US, EU; eyes chronic growth in India

Lupin to boost complex generics in US, EU; eyes chronic growth in India

Growth Triggers Line Up for Divi’s Labs

Growth Triggers Line Up for Divi’s Labs

From generic drugs to vaccines, Indian pharma industry is transforming lives worldwide

From generic drugs to vaccines, Indian pharma industry is transforming lives worldwide